Mazdutide: tested on its own
35 studies: no other medicine in its arm. Page 1 of 1. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.
- Efficacy, Safety and Cardiovascular Protection of Mazdutide in Type 1 DiabetesNot yet recruitingNCT07924553Not applicableReport a problem
- Mazdutide for Reducing Atrial Fibrillation Recurrence After Catheter Ablation in Obese PatientsNot yet recruitingNCT07897305Not applicableReport a problem
- Mazdutide for Weight Management and Gout in Adults With ObesityNot yet recruitingNCT07824895Phase 4Report a problem
- Efficacy of Mazdutide on Fatty PancreasNot yet recruitingNCT07803705Not applicableReport a problem
- Body-weight Reduction Effect on Portal Hypertension in Compensated CirrhosisNot yet recruitingNCT07797101Not applicableReport a problem
- Mazdutide for Remission of Type 2 Diabetes: Multicentre, Double Blind, Randomised, Placebo Controlled TrialNot yet recruitingNCT07767552Not applicableReport a problem
- Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)RecruitingNCT07718126Phase 4Report a problem
- Effect of Mazdutide on Coronary Plaque in Patients With Coronary Atherosclerosis and Overweight or ObesityRecruitingNCT07657676Phase 4Report a problem
- Mazdutide for Adults With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled Trial (DREAM-PRE)Not yet recruitingNCT07654062Phase 4Report a problem
- ASCEND-1: Lifestyle Intervention Plus Mazdutide for Weight ManagementRecruitingNCT07517042Not applicableReport a problem
- Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/ObesityRecruitingNCT07469800Phase 3Report a problem
- A Study of IBI362 in Chinese Adolescents With Obesity or OverweightRecruitingNCT07255209Phase 3Report a problem
- Mazdutide in Type 2 Diabetes With Early-Stage Cognitive Impairment (LIGHT-COG Study)RecruitingNCT07083154Phase 3Report a problem
- A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2RecruitingNCT06931028Phase 3Report a problem
- A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or OverweightCompletedNCT06124807Phase 2Results postedReport a problem
- Tolerance and Pharmacokinetic/Pharmacokinetic Study of IBI362 15mg in Patients With Moderate to Severe ObesityActive, not recruitingNCT07000955Phase 1/2Report a problem
- A Study of IBI362 in Participants With Metabolic Dysfunction-Associated Steatohepatitis (MASH)Active, not recruitingNCT06937749Phase 2Report a problem
- A Study Comparing IBI362 vs Semaglutide in Chinese Overweight or Obese Adults With Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD)Active, not recruitingNCT06884293Phase 3Report a problem
- A Study of IBI362 in Subjects With HFpEF or HFmrEF Combined With ObesityActive, not recruitingNCT06862908Phase 2Report a problem
- A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use DisorderCompletedNCT06817356Phase 2Report a problem
- This is a Study to Evaluate the Pharmacokinetics and Safety of IBI362 in Chinese Adolescents With ObesityCompletedNCT06536023Phase 1Report a problem
- Efficacy of Mazdutide for Treating PCOSCompletedNCT06519656Phase 1/2Report a problem
- A Study Comparing IBI362 vs Semaglutide in Chinese Adults With Early Type 2 Diabetes and ObesityCompletedNCT06184568Phase 3Report a problem
- A Study of IBI362 9 mg in Chinese Adults With ObesityActive, not recruitingNCT06164873Phase 3Report a problem
- Pharmacokinetics of IBI362 in Subjects With and Without Renal ImpairmentCompletedNCT05793450Phase 1Report a problem
- A Study of IBI362 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and ExerciseCompletedNCT05628311Phase 3Report a problem
- A Study of LY3305677 in Participants With Obesity Or OverweightCompletedNCT05623839Phase 1Report a problem
- A Study of IBI362 in Participants With Obesity or OverweightCompletedNCT05607680Phase 3Report a problem
- A Study of IBI362 in Chinese Patients With Type 2 DiabetesCompletedNCT04965506Phase 2Report a problem
- A Study of IBI362 Evaluating Weight Loss in Obese and Overweight Chinese SubjectsCompletedNCT04904913Phase 2Report a problem
- Clinical Study of IBI362 in Healthy Chinese Male SubjectsCompletedNCT04773977Phase 1Report a problem
- Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI362 in Overweight or Obesity SubjectsCompletedNCT04440345Phase 1/2Report a problem
- A Study of LY3305677 in Participants With Type 2 DiabetesCompletedNCT03928379Phase 1Report a problem
- A Study of Multiple Doses of LY3305677 in Healthy ParticipantsCompletedNCT03325387Phase 1Report a problem
- A Study of LY3305677 in Healthy ParticipantsCompletedNCT02972645Phase 1Report a problem